FAK/PYK2 promotes the Wnt/β-catenin pathway and intestinal tumorigenesis by phosphorylating GSK3β.
about
WNT-SHH Antagonism Specifies and Expands Stem Cells prior to Niche Formation.MAP4K4 is a novel MAPK/ERK pathway regulator required for lung adenocarcinoma maintenance.Gene expression and pathway analysis of CTNNB1 in cancer and stem cells.Transducin (β)-like 1 X-linked receptor 1 promotes gastric cancer progression via the ERK1/2 pathway.New Treatment Opportunities in Phosphatase and Tensin Homolog (PTEN)-Deficient Tumors: Focus on PTEN/Focal Adhesion Kinase Pathway.Focal adhesion kinase signaling in unexpected places.Targeting the programmed death-1 pathway in lymphoid neoplasms.Inhibition of FAK kinase activity preferentially targets cancer stem cellsInhibition of the integrin/FAK signaling axis and c-Myc synergistically disrupts ovarian cancer malignancy.Molecular mechanism underlying the pharmacological interactions of the protein kinase C-β inhibitor enzastaurin and erlotinib in non-small cell lung cancer cellsDifferences in p53 status significantly influence the cellular response and cell survival to 1,25-dihydroxyvitamin D3-metformin cotreatment in colorectal cancer cells.Wnt/β-catenin pathway activation mediates adaptive resistance to BRAF inhibition in colorectal cancer.Proline-Rich Protein Tyrosine Kinase 2 in Inflammation and Cancer.Methylation-Mediated Silencing of GATA5 Gene Suppresses Cholangiocarcinoma Cell Proliferation and Metastasis.PYK2 negatively regulates the Hippo pathway in TNBC by stabilizing TAZ protein
P2860
Q30750471-09772538-9BC4-4231-878B-B773A15D2A9AQ33787343-002EFD84-0E34-496F-B496-16FB30B00341Q37430859-F805A409-DA36-4A0E-9786-C2CBE664C5B2Q37736264-034542C6-F6F8-4FB9-8162-504A94B91DBAQ38604713-632B37ED-12D6-420F-8C28-8B9D892677EBQ39141363-24A24CB5-AE66-4072-A521-DCFA40A3CB1FQ39153358-4D8F0B5A-9E9E-43B5-A9BA-585AEEB73824Q41612992-902B1378-A82F-4135-BEAE-CCB0BE4CB65DQ42032794-A6E9E3E4-7978-47A3-B8D3-7A0132383ED9Q42290027-91C0AA7F-AF8F-40B9-A441-AA04056FD016Q47861796-7FE3653D-A329-4359-BFD4-347897580A9FQ49788106-C5864A76-295D-41F4-A461-279FCC65D57FQ54111596-E5C9C170-F1D2-474E-9137-E4195E2DE1EDQ54999003-DA30D33D-3259-48F5-A48D-B48D8BF16E20Q58700618-C9889712-FF98-4471-8BBF-D81CAEDCA8D1
P2860
FAK/PYK2 promotes the Wnt/β-catenin pathway and intestinal tumorigenesis by phosphorylating GSK3β.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
FAK/PYK2 promotes the Wnt/β-ca ...... esis by phosphorylating GSK3β.
@ast
FAK/PYK2 promotes the Wnt/β-ca ...... esis by phosphorylating GSK3β.
@en
type
label
FAK/PYK2 promotes the Wnt/β-ca ...... esis by phosphorylating GSK3β.
@ast
FAK/PYK2 promotes the Wnt/β-ca ...... esis by phosphorylating GSK3β.
@en
prefLabel
FAK/PYK2 promotes the Wnt/β-ca ...... esis by phosphorylating GSK3β.
@ast
FAK/PYK2 promotes the Wnt/β-ca ...... esis by phosphorylating GSK3β.
@en
P2093
P2860
P356
P1433
P1476
FAK/PYK2 promotes the Wnt/β-ca ...... esis by phosphorylating GSK3β.
@en
P2093
Chenxi Gao
David D Schlaepfer
Dennis Han Zhang
Guangming Chen
Shih-Fan Kuan
P2860
P356
10.7554/ELIFE.10072
P407
P577
2015-08-14T00:00:00Z